Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
IF: 2.9 5-Year IF: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Print: 0743-4863
ISSN Online: 2162-660X

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i5.20
pages 465-492

Pharmacogenomics and Its Potential Impact on Drug and Formulation Development

Karin Regnstrom
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA
Diane J. Burgess
Professor, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA

ABSTRACT

Recent advances in genomic research have provided the basis for new insights into the importance of genetic and genomic markers during the different stages of drug development. A new field of research, pharmacogenomics, which studies the relationship between drug effects and the genome, has emerged. Structural pharmacogenomics maps the complete DNA sequences of whole genomes (genotypes) including individual variations, and functional pharmacogenomics assesses the expression levels of thousands of genes in one single experiment. Together, these two areas of pharmacogenomics have generated massive databases, which have become a challenge for the research field of informatics and have fostered a new branch of research, bioinformatics. If skillfully used, the databases generated by pharmacogenomics together with data mining on the Web promise to improve the drug development process in a variety of areas: identification of drug targets, evaluation of toxicity, classification of diseases, evaluation of formulations, assessment of drug response and treatment, post-marketing applications, and development of personalized medicines.


Articles with similar content:

Clinical Genomics: Challenges and Opportunities
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 2
Jeffrey P. Greenfield, Christopher E. Mason, Alexa B. R. McIntyre, Priyanka Vijay, Sheng Li
Stealth Engineering for In Vivo Drug Delivery Systems
Critical Reviews™ in Biomedical Engineering, Vol.43, 2015, issue 5-6
Ankita Mohapatra, Richard A. Smith, Bashir I. Morshed, Warren O. Haggard
Measuring MicroRNA Expression Levels in Oncology: from Samples to Data Analysis
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 4
Silvana Canevari, Maurizio Callari, Loris De Cecco, Maria Grazia Daidone, Matteo Dugo
Liquid Biopsies in the Screening of Oncogenic Mutations in NSCLC and its Application in Targeted Therapy
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
David Chia, Jason H. Tang
Molecular Mechanisms Underlying the Role of MicroRNAs in Resistance to Epidermal Growth Factor Receptor-Targeted Agents and Novel Therapeutic Strategies for Treatment of Non-Small-Cell Lung Cancer
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 4
Elena Galvani, Godefridus J. Peters, Mina Maftouh, Elisa Giovannetti, Amir Avan